Stock Groups

Russia sees no hurdles for WHO approval of Sputnik V vaccine By Reuters

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: A worker holds a vial of Sputnik vaccinations at Hankook Korus Pharm’s Chuncheon plant, South Korea, September 10, 2021. Picture taken September 10, 2021. REUTERS/Heo Ran

MOSCOW (Reuters). – Russia’s Sputnik V and COVID-19 vaccine registrations have been completed. Only paperwork is left to finish, Mikhail Murashko (Russian Health Minister) said Saturday.

Sputnik V is a popular Russian shot that has been licensed for use in 70+ countries. It currently underwent a WHO/EMA review. The shot could be available in new markets, particularly Europe, if they are approved.

Murashko met Tedros Ghebreyesus, WHO Director-General in Geneva.

Interfax reported Murashko saying that Russia’s view on the promotion and registration Sputnik V was heard.

According to him, the company that is handling Sputnik V registration at WHO “only has to sign a few papers and submit a few more papers”.

Unfortunately, the WHO was not immediately available for comment.

In July, the WHO stated that it had discovered some problems with how Russia produced the Sputnik V vaccination. Manufacturer said that it now addresses all concerns raised by the WHO.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]